Literature DB >> 34046630

Assessment of the rules related to gaining activity against Gram-negative bacteria.

Henni-Karoliina Ropponen1,2, Eleonora Diamanti1, Alexandra Siemens3, Boris Illarionov3, Jörg Haupenthal1, Markus Fischer3, Matthias Rottmann4,5, Matthias Witschel6, Anna K H Hirsch1,2.   

Abstract

In the search for new antibacterial compounds, we repositioned an antimalarial compound class by derivatising it based on the so-called "eNTRy" rules for enhanced accumulation into Gram-negative bacteria. We designed, synthesised and evaluated a small library of amino acid modified compounds together with the respective Boc-protected analogues, leading to no substantial improvement in antibacterial activity against Escherichia coli wild-type K12, whereas more distinct activity differences were observed in E. coli mutant strains ΔtolC, D22, ΔacrB and BL21(DE3)omp8. A comparison of the activity results of the E. coli mutants with respect to the known rules related to enhanced activity against Gram-negative bacteria revealed that applicability of the rules is not always ensured. Out of the four amino acids used in this study, glycine derivatives showed highest antibacterial activity, although still suffering from efflux issues. This journal is © The Royal Society of Chemistry.

Entities:  

Year:  2021        PMID: 34046630      PMCID: PMC8128065          DOI: 10.1039/d0md00409j

Source DB:  PubMed          Journal:  RSC Med Chem        ISSN: 2632-8682


  34 in total

Review 1.  Mastering the Gram-negative bacterial barrier - Chemical approaches to increase bacterial bioavailability of antibiotics.

Authors:  Henni-Karoliina Ropponen; Robert Richter; Anna K H Hirsch; Claus-Michael Lehr
Journal:  Adv Drug Deliv Rev       Date:  2021-03-08       Impact factor: 15.470

2.  Structure-activity correlations for antibacterial agents on gram-positive and gram-negative cells.

Authors:  E J Lien; C Hansch; S M Anderson
Journal:  J Med Chem       Date:  1968-05       Impact factor: 7.446

3.  Predictive compound accumulation rules yield a broad-spectrum antibiotic.

Authors:  Michelle F Richter; Bryon S Drown; Andrew P Riley; Alfredo Garcia; Tomohiro Shirai; Riley L Svec; Paul J Hergenrother
Journal:  Nature       Date:  2017-05-10       Impact factor: 49.962

4.  Gram-Negative Antibiotic Active Through Inhibition of an Essential Riboswitch.

Authors:  Stephen E Motika; Rebecca J Ulrich; Emily J Geddes; Hyang Yeon Lee; Gee W Lau; Paul J Hergenrother
Journal:  J Am Chem Soc       Date:  2020-06-08       Impact factor: 15.419

5.  RNAse A-like enzymes in serum inhibit the anti-neoplastic activity of siRNA targeting polo-like kinase 1.

Authors:  Jörg Haupenthal; Christina Baehr; Stefan Zeuzem; Albrecht Piiper
Journal:  Int J Cancer       Date:  2007-07-01       Impact factor: 7.396

6.  Optimization and Mechanistic Characterization of Pyridopyrimidine Inhibitors of Bacterial Biotin Carboxylase.

Authors:  Logan D Andrews; Timothy R Kane; Paola Dozzo; Cat M Haglund; Darin J Hilderbrandt; Martin S Linsell; Timothy Machajewski; Glen McEnroe; Alisa W Serio; Kenneth B Wlasichuk; David B Neau; Svetlana Pakhomova; Grover L Waldrop; Marc Sharp; Joe Pogliano; Ryan T Cirz; Frederick Cohen
Journal:  J Med Chem       Date:  2019-08-09       Impact factor: 7.446

Review 7.  Development of inhibitors of the 2C-methyl-D-erythritol 4-phosphate (MEP) pathway enzymes as potential anti-infective agents.

Authors:  Tiziana Masini; Anna K H Hirsch
Journal:  J Med Chem       Date:  2014-09-25       Impact factor: 7.446

8.  Inhibitors of the kinase IspE: structure-activity relationships and co-crystal structure analysis.

Authors:  Anna K H Hirsch; Magnus S Alphey; Susan Lauw; Michael Seet; Luzi Barandun; Wolfgang Eisenreich; Felix Rohdich; William N Hunter; Adelbert Bacher; François Diederich
Journal:  Org Biomol Chem       Date:  2008-06-02       Impact factor: 3.876

9.  Optimized arylomycins are a new class of Gram-negative antibiotics.

Authors:  Peter A Smith; Michael F T Koehler; Hany S Girgis; Donghong Yan; Yongsheng Chen; Yuan Chen; James J Crawford; Matthew R Durk; Robert I Higuchi; Jing Kang; Jeremy Murray; Prasuna Paraselli; Summer Park; Wilson Phung; John G Quinn; Tucker C Roberts; Lionel Rougé; Jacob B Schwarz; Elizabeth Skippington; John Wai; Min Xu; Zhiyong Yu; Hua Zhang; Man-Wah Tan; Christopher E Heise
Journal:  Nature       Date:  2018-09-12       Impact factor: 49.962

10.  In situ structure and assembly of the multidrug efflux pump AcrAB-TolC.

Authors:  Xiaodong Shi; Muyuan Chen; Zhili Yu; James M Bell; Hans Wang; Isaac Forrester; Heather Villarreal; Joanita Jakana; Dijun Du; Ben F Luisi; Steven J Ludtke; Zhao Wang
Journal:  Nat Commun       Date:  2019-06-14       Impact factor: 14.919

View more
  1 in total

1.  Biotinylation as a tool to enhance the uptake of small molecules in Gram-negative bacteria.

Authors:  Ankit Pandeya; Ling Yang; Olaniyi Alegun; Chamikara Karunasena; Chad Risko; Zhenyu Li; Yinan Wei
Journal:  PLoS One       Date:  2021-11-12       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.